Teleflex Incorporated

Healthcare US TFX

111.99USD
0.15(0.13%)

Last update at 2026-03-11T14:58:00Z

Day Range

110.19112.36
LowHigh

52 Week Range

177.34274.74
LowHigh

Fundamentals

  • Previous Close 111.84
  • Market Cap11775.67M
  • Volume101100
  • P/E Ratio29.27
  • Dividend Yield0.54%
  • EBITDA807.90M
  • Revenue TTM2958.58M
  • Revenue Per Share TTM63.01
  • Gross Profit TTM 1550.09M
  • Diluted EPS TTM8.56

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 445.92M 559.47M 357.73M 339.90M 219.63M
Minority interest - - - - 0.00000M
Net income 363.14M 485.37M 335.32M 461.47M 200.80M
Selling general administrative 863.75M 860.09M 743.57M 934.37M 878.69M
Selling and marketing expenses - - - - -
Gross profit 1531.09M 1549.60M 1324.87M 1491.61M 1384.44M
Reconciled depreciation 230.59M 237.36M 227.25M 214.06M 209.98M
Ebit 499.73M 628.10M 423.07M 427.25M 400.49M
Ebitda 745.02M 797.37M 689.97M 659.18M 610.47M
Depreciation and amortization 245.30M 169.27M 266.90M 231.93M 209.98M
Non operating income net other 0.46M -11.65800M 1.16M -7.08100M 0.94M
Operating income 499.73M 628.10M 423.07M 427.25M 321.70M
Other operating expenses 2277.52M 2250.89M 2075.60M 2151.98M 2048.84M
Interest expense 54.26M 56.97M 66.49M 80.27M 103.02M
Tax provision 83.00M 74.35M 21.93M -122.07800M 23.20M
Interest income 53.35M 55.64M 1.16M 1.74M 0.94M
Net interest income -53.35200M -55.64100M -65.33600M -78.52900M -102.07600M
Extraordinary items 0.22M 0.26M -0.47700M -0.51500M 4.37M
Non recurring 20.30M 21.74M 38.49M 22.20M 79.23M
Other items - - - - -
Income tax expense 83.00M 74.35M 21.93M -122.07800M 23.20M
Total revenue 2791.04M 2809.56M 2537.16M 2595.36M 2448.38M
Total operating expenses 1017.57M 990.93M 863.32M 1048.23M 984.90M
Cost of revenue 1259.95M 1259.96M 1212.28M 1103.75M 1063.94M
Total other income expense net -53.80600M -68.62700M -65.33600M -87.35100M -77.84200M
Discontinued operations 0.22M 0.26M -0.47700M -0.51500M 4.37M
Net income from continuing ops 362.92M 485.12M 335.80M 461.98M 196.43M
Net income applicable to common shares 363.14M 485.37M 335.32M 461.47M 200.80M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 6928.06M 6871.72M 7152.56M 6309.82M 6277.99M
Intangible assets 2306.16M 2289.07M 2519.75M 2156.28M 2325.05M
Earning assets - - - - -
Other current assets 125.08M 117.28M 115.44M 97.94M 72.48M
Total liab 2906.09M 3116.97M 3816.10M 3330.50M 3738.01M
Total stockholder equity 4021.97M 3754.75M 3336.46M 2979.32M 2539.98M
Deferred long term liab - - - 439.56M 608.22M
Other current liab 367.19M 55.63M 53.87M 181.49M 383.18M
Common stock 47.96M 47.93M 47.81M 47.54M 47.25M
Capital stock 47.96M 47.93M 47.81M 47.54M 47.25M
Retained earnings 3817.30M 3517.95M 3096.23M 2824.92M 2427.60M
Other liab 580.14M 580.72M 812.09M 807.13M 1075.56M
Good will 2536.73M 2504.20M 2585.97M 2245.30M 2246.58M
Other assets 95.77M 75.92M 150.51M 44.95M 37.42M
Cash 292.03M 445.08M 375.88M 301.08M 357.16M
Cash and equivalents 292.03M 445.08M 375.88M 301.08M 357.16M
Total current liabilities 581.49M 680.12M 540.03M 563.05M 582.46M
Current deferred revenue - 396.25M 283.14M 228.65M 5.94M
Net debt 1539.93M 1521.05M 2188.61M 1709.23M 1801.66M
Short term debt 87.50M 110.00M 100.50M 50.00M 86.62M
Short long term debt 87.50M 110.00M 100.50M 50.00M 86.62M
Short long term debt total 1831.96M 1966.13M 2564.49M 2010.32M 2158.82M
Other stockholder equity 560.23M 535.82M 489.71M 451.26M 406.22M
Property plant equipment 578.42M 573.41M 473.91M 430.72M 432.77M
Total current assets 1410.98M 1429.12M 1422.42M 1306.33M 1236.17M
Long term investments - - - 13.07M -
Net tangible assets -820.92700M -1038.52100M -1769.25500M -1422.27000M -2031.65300M
Short term investments - - - - -
Net receivables 408.83M 383.57M 395.07M 418.67M 366.29M
Long term debt 1624.02M 1740.10M 2377.89M 1858.94M 2072.20M
Inventory 578.51M 477.64M 513.20M 476.56M 427.78M
Accounts payable 126.81M 118.24M 102.52M 102.92M 106.71M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -403.52200M -346.95900M -297.29800M -344.39200M -341.08500M
Additional paid in capital - - - - -
Common stock total equity 47.96M 47.93M 47.81M 47.54M 47.25M
Preferred stock total equity - - - - -
Retained earnings total equity 3817.30M 3517.95M 3096.23M 2824.92M 2427.60M
Treasury stock -154.88900M -157.26600M -162.59000M -165.72000M -168.54500M
Accumulated amortization - - - - -
Non currrent assets other 89.37M 69.10M 41.80M 52.45M 34.98M
Deferred long term asset charges - - - - -
Non current assets total 5517.08M 5442.60M 5730.13M 5003.49M 5041.82M
Capital lease obligations 120.44M 116.03M 86.10M 101.37M -
Long term debt total 1624.02M 1740.10M 2377.89M 1858.94M 2072.20M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -257.94100M -18.41800M 19.34M 18.33M 1.55M
Change to liabilities -104.23900M 94.02M -12.64800M 29.49M 26.66M
Total cashflows from investing activities -257.94100M 156.74M -837.78300M -73.48100M -196.39400M
Net borrowings -145.45000M -634.50000M 566.56M 275.00M 35.00M
Total cash from financing activities -217.50600M -715.82200M 455.16M -418.83600M -206.43300M
Change to operating activities 13.42M -28.41000M -4.32300M -31.02300M -10.35100M
Net income 363.14M 485.37M 335.32M 461.47M 200.80M
Change in cash -153.05000M 69.20M 74.80M -56.07800M 23.60M
Begin period cash flow 445.08M 375.88M 301.08M 357.16M 333.56M
End period cash flow 292.03M 445.08M 375.88M 301.08M 357.16M
Total cash from operating activities 342.14M 651.42M 436.41M 439.52M 437.38M
Issuance of capital stock 0.00000M 11.10M - - -
Depreciation 230.59M 237.36M 227.25M 214.06M 209.98M
Other cashflows from investing activities -178.75100M 228.35M -766.43000M 14.35M 3.88M
Dividends paid -63.78900M -63.64800M -63.22100M -62.82800M 62.16M
Change to inventory -110.68600M -11.13800M -5.49700M -53.17000M -37.19800M
Change to account receivables -38.45900M -0.60000M 44.75M -59.79300M -23.41200M
Sale purchase of stock -4.30800M 412.45M 18.99M 21.21M 22.66M
Other cashflows from financing activities 730.78M -41.22200M 1457.19M 172.49M -15.76800M
Change to netincome -6.15700M -203.15500M -74.78600M -93.64500M 14.57M
Capital expenditures 79.19M 71.62M 90.69M 102.69M 80.80M
Change receivables -38.45900M -0.60000M 44.75M -59.79300M -23.41200M
Cash flows other operating 3.90M -115.80400M -82.41700M -63.19200M 41.24M
Exchange rate changes - - - - -10.94800M
Cash and cash equivalents changes -134.11000M 93.05M 54.52M -55.24900M 23.60M
Change in working capital -239.96400M 127.34M 22.28M -114.49600M -44.29700M
Stock based compensation 27.22M 22.94M 20.74M 26.94M 22.44M
Other non cash items -25.84000M -111.36000M -136.51400M 20.15M 54.55M
Free cash flow 262.95M 579.80M 345.71M 336.83M 356.58M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
TFX
Teleflex Incorporated
0.15 0.13% 111.99 29.27 17.27 4.00 2.70 4.36 16.14
ISRG
Intuitive Surgical Inc
-0.54 0.11% 485.31 73.05 61.73 19.15 10.25 18.41 59.92
ESLOY
Essilor International SA
-1.02 0.83% 121.48 35.39 24.81 3.63 2.20 4.00 16.25
ESLOF
EssilorLuxottica Société anonyme
- -% 243.04 35.71 25.13 3.62 2.23 4.00 16.25
BDX
Becton Dickinson and Company
-0.39 0.24% 163.49 37.72 15.92 3.25 2.49 4.08 17.10

Reports Covered

Stock Research & News

Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Teleflex Incorporated

550 East Swedesford Road, Wayne, PA, United States, 19087-1603

Key Executives

Name Title Year Born
Mr. Liam J. Kelly Chairman, Pres & CEO 1967
Mr. Thomas E. Powell Exec. VP & CFO 1962
Mr. Cameron P. Hicks Corp. VP & Chief HR Officer 1965
Mr. Jay White Corp. VP & Pres of Global Commercial 1974
Mr. James P. Winters Corp. VP, Manufacturing and Supply Chain NA
Mr. John R. Deren Corp. VP & Chief Accounting Officer NA
Mr. John Hsu C.F.A. VP of Investor Relations NA
Mr. Daniel V. Logue Corp. VP, Gen. Counsel & Sec. 1974
Mr. Howard Cyr Corp. VP & Chief Compliance Officer NA
Mr. Matt Tomkin VP of Corp. Devel. NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.